Download Massachusetts General Hospital to Install IMRISneuro

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Dual consciousness wikipedia , lookup

Neurophilosophy wikipedia , lookup

Allochiria wikipedia , lookup

Positron emission tomography wikipedia , lookup

Neuromarketing wikipedia , lookup

Cognitive neuroscience wikipedia , lookup

Neuroinformatics wikipedia , lookup

History of neuroimaging wikipedia , lookup

Transcript
FOR IMMEDIATE RELEASE
MASSACHUSETTS GENERAL HOSPITAL TO INSTALL IMRISneuro
Leadership in Neuroscience Continues with New Imaging System
Winnipeg, Manitoba, July 29, 2009 – IMRIS Inc. (TSX: IM) ("IMRIS" or the
“Company”) announced today that Massachusetts General Hospital has selected
IMRISneuro as the latest investment for its world-leading imaging and neurosurgical
services.
Massachusetts General Hospital’s Department of Radiology will install IMRIS’ 3Tesla
MRI in its new “Building for the 3rd Century”. This one-of-a-kind technology will allow
Mass General’s Neurosurgery team to scan with the MRI during surgical procedures.
The result is timely, high resolution images and critical patient information without
ever moving the patient. The IMRISneuro system installed at Mass General will
provide leading edge, multi-functional capabilities to the neuroscience team.
David Graves, President and CEO of IMRIS commented: “The adoption of our
technology by leaders in neuroscience continues to validate IMRISneuro as the intraoperative imaging solution of choice.”
About IMRIS
IMRIS (TSX: IM) is a global leader in providing fully integrated, advanced surgical
imaging solutions. The company's flagship product, IMRISneuro, utilizes patented
technology that allows a high field MRI scanner to be moved in to the operating room
on demand, providing imaging during the surgical procedure without compromising
patient safety. This unique and innovative system has been validated by leading
neurosurgeons for use in world-class neuroscience centers.
For more information, visit www.imris.com.
- 30 For further information:
Media:
Michael Robbie
Director, Marketing
Tel: (204) 480-7696
Email: [email protected]
Investors:
Brad Woods
Director Investor Relations
& Corporate Communications
Tel: (204) 480-7094
Email: [email protected]